Ein neues Konzept zur Untersuchung lymphangiogener Faktoren beim Pankreaskarzinom

  • M. Schneider
  • P. Büchler
  • A. Ny
  • M. Koch
  • N. Giese
  • M. W. Büchler
  • H. Friess
  • P. Carmeliet
Conference paper
Part of the Deutsche Gesellschaft für Chirurgie book series (DTGESCHIR, volume 35)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Milsmann C, Fuzesi L, Werner C, Becker H, Horstmann O (2005) Significance of occult lymphatic tumor spread in pancreatic cancer. Chirurg 76: 1064–1072PubMedCrossRefGoogle Scholar
  2. 2.
    Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438: 946–953PubMedCrossRefGoogle Scholar
  3. 3.
    Lawson ND, Weinstein BM (2002) Arteries and veins: making a difference with zebrafish. Nat Rev Genet 3: 674–682PubMedCrossRefGoogle Scholar
  4. 4.
    Wigle JT, Oliver G (1999) Prox1 function is required for the development of the murine lymphatic system. Cell 98: 769–778PubMedCrossRefGoogle Scholar
  5. 5.
    Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74–80PubMedCrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2006

Authors and Affiliations

  • M. Schneider
    • 1
    • 2
  • P. Büchler
    • 2
  • A. Ny
    • 1
  • M. Koch
    • 1
  • N. Giese
    • 2
  • M. W. Büchler
    • 2
  • H. Friess
    • 2
  • P. Carmeliet
    • 1
  1. 1.Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for BiotechnologyKULeuvenLeuvenBelgium
  2. 2.Chirurgische Universitätsklinik der Ruprecht-Karls-Universität HeidelbergHeidelbergDeutschland

Personalised recommendations